Who we are

differenciation_adipocytaire
©K. Tarte-U916 Inserm

 

ECELLFRANCE is the French Network Infrastructure for mesenchymal stem cell (MSC)-based therapies.

 

Since its creation in 2012, it has been involved in over 20 national and European research & innovation programs in cell-based therapy.

 

It brings together :

  • State-of-the-art Advanced Therapy Medicinal Products (ATMP) production platforms
  • Immunomonitoring and quality control platforms
  • Research teams with expertise on translational research in cell therapy
  • Clinical research teams to cover phase I and II clinical studies 


In the fields of :

  • Osteoarticular diseases
  • Autoimmune diseases
  • Cutaneous conditions
  • Ischemia
  • Stroke and neurological disorders

 

Services
ECELLFRANCE is open to academics and industrials requesting support for their pre-clinical and/or clinical programs in the field of cell-based therapies. The infrastructure provides services covering the entire MSC-based production and development pipeline including:

- Project validation - Production of ATMP
- Immunomonitoring
- Preclinical studies

- Safety and potency tests


- Regulatory support

- Phase I and II clinical trials

 


Service requests can be submitted by filling the application form.

 

 

 

Brochure ECELLFRANCE

 

Brochure available here.

Partners

News

CELLS | Musculoskeletal 2016

AMSTERDAM, NETHERLANDS
OCTOBER 7-9, 2016

TRAINING: Thérapeutiques cellulaires et tissulaires, Prérequis réglementaires

PARIS

OCTOBER 10-11, 2016

 

>>> All news

Members

Contact


ECellFrance

Hôpital St-Eloi

Bâtiment IRMB

80 rue Augustin Fliche

34295 Montpellier cedex 5

FRANCE

Tel: +33 (0)4 67 33 57 23

contact@ecellfrance.com